September 18, 2018
Nineteen companies have joined the Japan Pharmaceutical Manufacturers Association’s (JPMA) task force on the quality evaluation of nucleic acid therapeutics. The task force, which was set up this spring, includes first and second-tier companies, both Japanese and foreign companies, indicating...read more